Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Warning Over Potentially Toxic Chinese Herbal Medicine

Published: Thursday, April 18, 2013
Last Updated: Thursday, April 18, 2013
Bookmark and Share
MHRA warn people not to use Zheng Tian Wan to treat migraines.

The MHRA is warning people not to use a particular Chinese herbal medicine, used to treat migraines, as it contains a potentially toxic herbal ingredient.

The product, Zheng Tian Wan consists of herbal pills which contain aconite, a poisonous plant toxic to the heart and the nervous system and linked to serious health complications including deaths.

This product has recently come to the attention of the MHRA as a result of being supplied to a patient by an herbal practitioner.

Aconite (also known as monkshood) is on a UK list of restricted herbal ingredients. Aconite should not be used in unlicensed products for oral use and Herbal practitioners in the UK should only use aconite in preparations for external use only on unbroken skin. It can be prescribed in oral medicines by a qualified medical doctor under supervision as a prescription-only medicine.

The product is an unlicensed herbal medicine which means it has not been assessed for safety and quality by the MHRA.

The MHRA has previously received three reports of suspected side effects to aconite, one where a patient suffered kidney problems a second person was hospitalized after suffering dizziness and ‘pins and needles’ (paraesthesia) and the third experienced palpitations, aches and pains with shortness of breath but recovered after stopping taking the product.

Andrea Farmer, Herbal Policy Manager at the MHRA said: “Herbal medicines can have a very significant effect on the body. In certain circumstances, such as with aconite taken orally, they can be extremely dangerous.

Products intended for oral use containing aconite are not permitted in the UK without appropriate authorization.

If users have taken Zheng Tian Wan or any other aconite -containing product, speak to their GP or healthcare professional as soon as possible.

“Natural does not mean safe. To help you choose an herbal medicine that is suitable for you, look for a product that has a Traditional Herbal Registration (THR) or product license number on the packaging. These products have met the acceptable quality and safety standards.

“And if you think you have suffered a side effect to an herbal medicine, please tell us about it through our Yellow Card Scheme at www.yellowcard.mhra.gov.uk.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

UK Moves Towards Safe and Effective Electronic Cigarettes and Other NCPs
All nicotine-containing products, such as electronic cigarettes, are to be regulated as medicines in a move to make these products safer and more effective to reduce the harms of smoking.
Friday, July 12, 2013
MHRA Appoints New Chief Executive
The Medicines and Healthcare Products Regulatory Agency (MHRA) announced the appointment of Dr Ian Hudson as its Chief Executive.
Friday, July 05, 2013
Man Jailed in Pre-Clinical Trial Data Scam Case
The man was sentenced to three months in prison for altering pre-clinical trial data designed to support applications to perform clinical trials.
Friday, April 19, 2013
MHRA Prioritises Science and Research Support as Part of New Corporate Plan
MHRA announced its aim to be a leading regulator on the world stage in supporting science and research as part of its new five-year corporate plan.
Monday, April 15, 2013
Side Effects to be Discovered more Quickly, Leading to Safer Prescribing
BMJ Learning has teamed up with the MHRA to launch a new, interactive and multimedia learning module on pharmacovigilance.
Monday, April 15, 2013
The Medicines Act Hits 40
The 25th October 2008 will mark the 40th birthday of the Medicines Act. For the past 40 years, the Act has served as the corner-stone of domestic medicines regulation, safe guarding public health.
Friday, October 24, 2008
New Web Resource About Medicines
From today, people can access a new authoritative source of information on the Internet about medicines.
Friday, September 26, 2008
British Pharmacopoeia Launches New Website
The Medicines and Healthcare products Regulatory Agency (MHRA) has today launched the new British Pharmacopoeia (BP) website www.pharmacopoeia.gov.uk.
Tuesday, September 09, 2008
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!